talent: neoadjuvant t-dxd with or without anastrozole for her2-low, hr early stage breast cancer
Published 1 year ago • 149 plays • Length 2:59Download video MP4
Download video MP3
Similar videos
-
4:15
debbrah: t-dxd in her2 or her2-low advanced breast cancer with cns involvement
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
1:32
destiny-breast15: t-dxd in patients with hr hr- and her2-low or her2 ihc 0 metastatic breast cancer
-
17:10
sabcs 2022: trio-us b-12 talent: neoadjuvant tdx with or without anastrozole for her2-low, hr e...
-
1:59
adapt: de-escalated neoadjuvant pertuzumab trastuzumab with or without paclitaxel in hr-/her2 ebc
-
2:05
tropion-breast04: dato-dxd and durvalumab in tnbc or hr-low/her2- breast cancer
-
0:44
destiny-breast12: t-dxd in patients with her2 /hr- breast cancer with brain metastasis
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
2:49
her2-e pcr with anti-her2-based neoadjuvant therapies
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
1:06
incorporating t-dxd in patients with her2 or her2-low bc and leptomeningeal carcinomatosis
-
2:01
destiny-breast04: practice-changing results for her2-low breast cancer
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
5:11
destiny-breast04: t-dxd provides significant improvement in os pfs in her2-low mbc
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
0:55
neoadjuvant treatment approach for her2 positive breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
6:51
adcs for her2 and her2-low breast cancer